9.62
price up icon0.63%   0.06
after-market Dopo l'orario di chiusura: 9.60 -0.02 -0.21%
loading
Precedente Chiudi:
$9.56
Aprire:
$9.54
Volume 24 ore:
11.93M
Relative Volume:
1.25
Capitalizzazione di mercato:
$11.22B
Reddito:
$14.33B
Utile/perdita netta:
$-3.79B
Rapporto P/E:
-3.0347
EPS:
-3.17
Flusso di cassa netto:
$1.84B
1 W Prestazione:
-6.05%
1M Prestazione:
-9.33%
6M Prestazione:
+4.00%
1 anno Prestazione:
-18.61%
Intervallo 1D:
Value
$9.52
$9.86
Intervallo di 1 settimana:
Value
$9.49
$10.38
Portata 52W:
Value
$6.85
$13.55

Viatris Inc Stock (VTRS) Company Profile

Name
Nome
Viatris Inc
Name
Telefono
(724) 514-1465
Name
Indirizzo
1000 MYLAN BOULEVARD, CANONSBURG
Name
Dipendente
32,000
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
VTRS's Discussions on Twitter

Confronta VTRS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
9.62 11.15B 14.33B -3.79B 1.84B -3.17
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
146.93 65.35B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.09 47.75B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.40 41.52B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.38 21.43B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
403.68 18.00B 2.99B 1.21B 1.13B 25.06

Viatris Inc Stock (VTRS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-06 Iniziato Goldman Neutral
2024-07-19 Ripresa Jefferies Buy
2023-10-23 Downgrade BofA Securities Neutral → Underperform
2023-06-23 Downgrade Barclays Equal Weight → Underweight
2023-04-24 Downgrade Barclays Overweight → Equal Weight
2023-02-17 Downgrade BMO Capital Markets Outperform → Market Perform
2023-01-27 Aggiornamento Jefferies Hold → Buy
2022-11-10 Aggiornamento UBS Sell → Neutral
2022-11-08 Aggiornamento Piper Sandler Underweight → Neutral
2022-10-21 Ripresa Jefferies Hold
2022-06-14 Iniziato UBS Sell
2022-05-10 Downgrade Piper Sandler Neutral → Underweight
2022-03-01 Downgrade BofA Securities Buy → Neutral
2022-03-01 Downgrade Raymond James Outperform → Mkt Perform
2021-06-15 Iniziato Citigroup Neutral
2021-04-07 Ripresa RBC Capital Mkts Outperform
2021-03-08 Downgrade Goldman Buy → Neutral
2021-03-02 Downgrade JP Morgan Overweight → Neutral
2021-02-26 Downgrade Wolfe Research Outperform → Peer Perform
2021-01-05 Iniziato Argus Hold
2020-12-14 Iniziato Bernstein Mkt Perform
Mostra tutto

Viatris Inc Borsa (VTRS) Ultime notizie

pulisher
03:01 AM

Viatris (VTRS) Recovers Slightly But Struggles Amid Market Conce - GuruFocus

03:01 AM
pulisher
02:20 AM

Day 7 of Loss Streak for Viatris Stock with -9% Return (vs. -20% YTD) [9/16/2025] - Trefis

02:20 AM
pulisher
Sep 16, 2025

Market Moves: Is now the right time to enter Viatris IncJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Viatris Inc. (VTRS) Enters $515M IV Iron Market With FDA Green Light - MSN

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Swings: Is now the right time to enter Viatris IncJuly 2025 Spike Watch & Target Return Focused Picks - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Market Leaders: Can Viatris Inc. navigate macro headwindsQuarterly Profit Report & Consistent Return Strategy Ideas - خودرو بانک

Sep 15, 2025
pulisher
Sep 14, 2025

Viatris chief commercial officer Le Goff sells $72k in stock - Investing.com Nigeria

Sep 14, 2025
pulisher
Sep 12, 2025

Viatris chief commercial officer Le Goff sells $72k in stock By Investing.com - Investing.com South Africa

Sep 12, 2025
pulisher
Sep 11, 2025

Real time scanner hits for Viatris Inc. explainedMarket Trend Review & Low Risk Profit Maximizing Plans - Newser

Sep 11, 2025
pulisher
Sep 10, 2025

Viatris Investors Face Skeptical Judges on Biosimilars Unit (1) - Bloomberg Law News

Sep 10, 2025
pulisher
Sep 10, 2025

US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche - Yahoo Finance

Sep 10, 2025
pulisher
Sep 10, 2025

Viatris receives FDA warning letter for 11 drugs made at India plant - MSN

Sep 10, 2025
pulisher
Sep 09, 2025

Trend analysis for Viatris Inc. this weekTreasury Yields & Stepwise Trade Signal Guides - Newser

Sep 09, 2025
pulisher
Sep 09, 2025

Is Viatris Inc. Starting a New UptrendEarnings Summary Report & Reliable Momentum Entry Alerts - beatles.ru

Sep 09, 2025
pulisher
Sep 08, 2025

Viatris Inc. Forms Double Bottom Pattern — Eyes on Breakout2025 Market WrapUp & Fast Moving Market Watchlists - beatles.ru

Sep 08, 2025
pulisher
Sep 07, 2025

What makes Viatris Inc. stock attractive to long term investorsQuarterly Trade Report & AI Forecasted Stock Moves - beatles.ru

Sep 07, 2025
pulisher
Sep 07, 2025

Is Viatris Inc. reversing from oversold territoryPortfolio Performance Summary & Consistent Growth Equity Picks - Newser

Sep 07, 2025
pulisher
Sep 06, 2025

Custom strategy builders for tracking Viatris Inc.July 2025 Summary & Free Long-Term Investment Growth Plans - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Stock Analysis | Viatris OutlookA Technical Bear Market with Mixed Fundamentals - AInvest

Sep 06, 2025
pulisher
Sep 05, 2025

Candlestick signals on Viatris Inc. stock todayJuly 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

How volatile is Viatris Inc. stockJuly 2025 Action & Free High Accuracy Swing Entry Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Will a bounce in Viatris Inc. offer an exitJuly 2025 Short Interest & Weekly Top Performers Watchlists - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

When is the best time to exit Viatris Inc.Weekly Stock Analysis & Verified Chart Pattern Signals - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Generic Drugs Market is expected to reach US$ 942.69 billion - openPR.com

Sep 05, 2025
pulisher
Sep 05, 2025

How to escape a deep drawdown in Viatris Inc.Earnings Risk Summary & Smart Swing Trading Alerts - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

What high frequency data says about Viatris Inc.2025 Institutional Moves & Detailed Earnings Play Strategies - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How to use a screener to detect Viatris Inc. breakoutsVolume Spike & Expert Curated Trade Setups - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Fda discontinues manufacture of Dymista, nasal spray, 137 ug 50 ug - MarketScreener

Sep 04, 2025
pulisher
Sep 04, 2025

How to use Fibonacci retracement on Viatris Inc.2025 Earnings Surprises & Weekly Return Optimization Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Zacks Investment Ideas feature highlights: Church & Dwight, Eli Lilly and Viatris - sharewise.com

Sep 04, 2025
pulisher
Sep 03, 2025

Using economic indicators to assess Viatris Inc. potential2025 Risk Factors & Expert Curated Trade Setups - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Risk adjusted return profile for Viatris Inc. analyzedGold Moves & Verified Momentum Stock Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How moving averages guide Viatris Inc. trading2025 Key Highlights & Daily Profit Maximizing Trade Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using fundamentals and technicals on Viatris Inc.Earnings Recap Report & Expert Approved Momentum Trade Ideas - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Evaluating Viatris Inc. with trendline analysisEarnings Performance Report & Safe Capital Growth Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Statistical indicators supporting Viatris Inc.’s strengthStock Surge & Risk Adjusted Buy/Sell Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can machine learning forecast Viatris Inc. recovery2025 Top Decliners & Fast Gain Swing Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Using data tools to time your Viatris Inc. exitJuly 2025 Outlook & AI Powered Trade Plan Recommendations - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can Viatris Inc. recover in the next quarterCPI Data & Expert Approved Momentum Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Viatris Inc. a cyclical or defensive stockJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

What are the risks of holding Viatris Inc.Weekly Risk Summary & Low Volatility Stock Suggestions - خودرو بانک

Sep 02, 2025
pulisher
Sep 01, 2025

Is Viatris Inc. stock a top performer YTDQuarterly Risk Review & Fast Exit and Entry Trade Guides - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Can Viatris Inc. deliver consistent EPS growthJuly 2025 Review & Stepwise Trade Signal Guides - خودرو بانک

Sep 01, 2025

Viatris Inc Azioni (VTRS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_specialty_generic RDY
$14.86
price up icon 0.88%
$18.43
price down icon 1.07%
$142.73
price up icon 1.30%
$27.87
price up icon 1.75%
$403.68
price up icon 1.43%
Capitalizzazione:     |  Volume (24 ore):